These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16378062)

  • 1. Study of mRNA growth factors in urinary cells of kidney transplant recipients as predictors of chronic allograft nephropathy.
    Mas VR; Maluf DG; Archer KJ; Yanek K; King A; Cotterell A; Ferreira-Gonzalez A; Rodgers C; Fisher RA; Posner M
    Transplantation; 2005 Dec; 80(12):1686-91. PubMed ID: 16378062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intragraft messenger RNA expression of angiotensinogen: relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients.
    Mas V; Alvarellos T; Giraudo C; Massari P; De Boccardo G
    Transplantation; 2002 Sep; 74(5):718-21. PubMed ID: 12352892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intragraft expression of transforming growth factor-beta 1 by a novel quantitative reverse transcription polymerase chain reaction ELISA in long lasting kidney recipients.
    Mas V; Diller A; Albano S; Giraudo C; Alvarellos T; Sena J; Massari P; de Boccardo G
    Transplantation; 2000 Aug; 70(4):612-6. PubMed ID: 10972219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and structural consequences of early renal allograft injury.
    Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1 expression and chronic allograft nephropathy in protocol kidney graft biopsy.
    Viklický O; Matl I; Voska L; Böhmová R; Jaresová M; Lácha J; Lodererová A; Stríz I; Teplan V; Vítko S
    Physiol Res; 2003; 52(3):353-60. PubMed ID: 12790768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction.
    Pribylova-Hribova P; Kotsch K; Lodererova A; Viklicky O; Vitko S; Volk HD; Lacha J
    Kidney Int; 2006 May; 69(10):1872-9. PubMed ID: 16612332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].
    Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F
    Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary transforming growth factor-beta1 excretion in renal allograft recipients during the early post-transplantation period.
    Goumenos DS; Tsakas S; Karavias D; Savidaki I; Karatzas T; Vlachojannis JG
    Ren Fail; 2003 Jul; 25(4):561-8. PubMed ID: 12911160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine excretion of transforming growth factor-beta1 in chronic allograft nephropathy.
    Boratyńska M
    Ann Transplant; 1999; 4(2):23-8. PubMed ID: 10850587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients.
    Cho JH; Huh S; Kwon TG; Choi JY; Hur IK; Lee EY; Park SH; Kim YL; Kim CD
    Transplant Proc; 2008 Sep; 40(7):2355-60. PubMed ID: 18790234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta 1 in renal allograft recipients.
    Coupes BM; Newstead CG; Short CD; Brenchley PE
    Transplantation; 1994 Jun; 57(12):1727-31. PubMed ID: 8016876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased urinary excretion of alpha1-microglobulin at 6 months after transplantation is associated with urinary excretion of transforming growth factor-beta1 and indicates poor long-term renal outcome.
    Teppo AM; Honkanen E; Finne P; Törnroth T; Grönhagen-Riska C
    Transplantation; 2004 Sep; 78(5):719-24. PubMed ID: 15371675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Messenger RNA for FOXP3 in the urine of renal-allograft recipients.
    Muthukumar T; Dadhania D; Ding R; Snopkowski C; Naqvi R; Lee JB; Hartono C; Li B; Sharma VK; Seshan SV; Kapur S; Hancock WW; Schwartz JE; Suthanthiran M
    N Engl J Med; 2005 Dec; 353(22):2342-51. PubMed ID: 16319383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy.
    Campistol JM; Iñigo P; Jimenez W; Lario S; Clesca PH; Oppenheimer F; Rivera F
    Kidney Int; 1999 Aug; 56(2):714-9. PubMed ID: 10432413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts.
    Afaneh C; Muthukumar T; Lubetzky M; Ding R; Snopkowski C; Sharma VK; Seshan S; Dadhania D; Schwartz JE; Suthanthiran M
    Transplantation; 2010 Dec; 90(12):1381-7. PubMed ID: 21079547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function.
    Mas VR; Mas LA; Archer KJ; Yanek K; King AL; Gibney EM; Cotterell A; Fisher RA; Posner M; Maluf DG
    Mol Med; 2007; 13(5-6):315-24. PubMed ID: 17622313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD103 mRNA levels in urinary cells predict acute rejection of renal allografts.
    Ding R; Li B; Muthukumar T; Dadhania D; Medeiros M; Hartono C; Serur D; Seshan SV; Sharma VK; Kapur S; Suthanthiran M
    Transplantation; 2003 Apr; 75(8):1307-12. PubMed ID: 12717221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cytomegalovirus infection on long-term renal allograft function].
    Tang B; Lv PY; Xu FY; Zheng KL; Liu D
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1588-91. PubMed ID: 19726300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum TGF-beta1 correlates with chronic histopathological lesions in protocol biopsies of kidney allograft recipients.
    Baczkowska T; Perkowska-Ptasińska A; Sadowska A; Lewandowski Z; Nowacka-Cieciura E; Cieciura T; Pazik J; Lewandowska D; Mroz A; Urbanowicz A; Nazarewski S; Danielewicz R
    Transplant Proc; 2005 Mar; 37(2):773-5. PubMed ID: 15848527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.